Ewa Żekanowska

Ewa Żekanowska

Auto-generated profile, based on publicly available information

Ewa Żekanowska

Department of Pathophysiology, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum, 85-094 Bydgoszcz, Poland

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
MŚMilena Świtońska
Milena Świtońska
NPNatalia Piekuś-Słomka
Natalia Piekuś-Słomka
Artur SłomkaArtur Słomka
Artur Słomka
Paweł SokalPaweł Sokal
Paweł Sokal
EŻEwa Żekanowska
Ewa Żekanowska
SLSimona Lattanzi
Simona Lattanzi
Objectives: Symptomatic hemorrhagic transformation (sHT) is a life-threatening complication of acute ischemic stroke (AIS). The early identification of the patients at increased risk of sHT can have clinically relevant implications. The aim of this study was to explore the validity and accuracy of the neutrophil-to-lymphocyte ratio (NLR) in predicting sHT in patients with AIS undergoing revascularization. Methods: Consecutive patients hospitalized for AIS who underwent intravenous thrombolysis, mechanical thrombectomy or both were identified. The NLR values were estimated at admission. The study endpoint was the occurrence of sHT within 24 h from stroke treatment. Results: Fifty-one patients with AIS were included, with a median age of 67 (interquartile range, 55–78) years. sHT occurred in 10 (19.6%) patients. Patients who developed sHT had higher NLR at admission. NLR was an independent predictor of sHT and showed good discriminatory power (area under the curve 0.81). In a multivariable analysis, NLR and systolic blood pressure were independently associated with sHT. Conclusions: NLR at admission can accurately predict sHT in patients with AIS undergoing revascularization.

20 June 2020 in Pathogens
Verified
Journal Article
Open access
PDF file
Artur SłomkaArtur Słomka
Artur Słomka
Mariusz KowalewskiMariusz Kowalewski
Mariusz Kowalewski
EŻEwa Żekanowska
Ewa Żekanowska
Infection with severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2) is a rapidly spreading and devastating global pandemic. Many researchers are attempting to clarify the mechanisms of infection and to develop a drug or vaccine against the virus, but there are still no proven effective treatments. The present article reviews the common presenting hematological manifestations of coronavirus disease 2019 (COVID–19). Elucidating the changes in hematological parameters in SARS–CoV–2 infected patients could help to understand the pathophysiology of the disease and may provide early clues to diagnosis. Several studies have shown that hematological parameters are markers of disease severity and suggest that they mediate disease progression.

1 April 2001 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
MUM. Uszyński
M. Uszyński
EŻE. Żekanowska
E. Żekanowska
WUW. Uszyński
W. Uszyński
JKJ. Kuczyński
J. Kuczyński

1 January 2014 in Gastroenterology Review
Verified
Journal Article
Open access
JPJustyna Przybyszewska
Justyna Przybyszewska
EŻEwa Żekanowska
Ewa Żekanowska
Iron is found in almost all foods, so dietary iron intake is related to energy intake. However, its availability for absorption is quite variable, and poor bioavailability is a major reason for the high prevalence of nutritional iron deficiency anaemia. Absorption occurs primarily in the...

5 November 2014 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MŚM. Świtońska
M. Świtońska
Artur SłomkaArtur Słomka
Artur Słomka
WSW. Sinkiewicz
W. Sinkiewicz
EŻE. Żekanowska
E. Żekanowska

5 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
MŚMilena Świtońska
Milena Świtońska
Artur SłomkaArtur Słomka
Artur Słomka
PKPiotr Korbal
Piotr Korbal
NPNatalia Piekuś-Słomka
Natalia Piekuś-Słomka
WSWładysław Sinkiewicz
Władysław Sinkiewicz
EŻEwa Żekanowska
Ewa Żekanowska
Background and Objectives: Ischaemic stroke (IS) is the leading cause of death and disability worldwide. All stages of cerebral ischaemia, but especially acute phase, are associated with inflammatory response. Recent studies showed that neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) may be used to assess inflammation in IS. To test whether there is a relationship between these parameters and type of stroke treatment, we analysed NLR and LMR in IS patients treated with three different modalities. Materials and Methods: The study included 58 adults with acute IS. A total of 28 patients received intravenous thrombolysis. In another 10 patients, the thrombolytic therapy was followed by thrombectomy and 20 patients did not undergo causal treatment. Blood samples were obtained within 24 h of the stroke diagnosis to calculate NLR and LMR. Next, NLR and LMR of the study subgroups were compared. Results: Our study revealed that NLR was significantly higher in patients treated with thrombectomy following thrombolysis, compared to no causal treatment. Statistical analysis demonstrated that patients with high National Institutes of Health Stroke Scale (NIHSS) scores presented higher NLR than in those with low NIHSS scores. Additionally, patients with high-sensitivity C-reactive protein (hs-CRP) ≥ 3 mg/L presented with significantly higher NLR and significantly lower LMR than the group of patients with lower hs-CRP (<3 mg/L). Conclusions: The main finding of this pilot study was that NLR in IS patients treated using thrombectomy following thrombolysis was markedly higher than that in other treatment groups, which was associated with increased severity of the disease in these patients. Therefore, patients with higher NLR may be expected to have more severe stroke. The link between stroke severity and NLR deserves further study.